“The district court’s finding that the claims were mutually exclusive ‘forced itself into a later conclusion of ...
The U.S. Patent and Trademark Office (USPTO) today announced that it will extend the comment period for its “2024 Guidance ...
“In effect, what the Negotiation Program does is marginally reduce the maximum value of a drug patent.” – P4AD amicus brief ...
The U.S. Chamber of Commerce’s Global Innovation Policy Center (GIPC) published a blog post Friday urging the U.S. Patent and ...